Baird Maintains Neutral on Medtronic, Lowers Price Target to $85

Benzinga Newsdesk www.benzinga.com Negative 71.1%

Neg 71.1% Neu 0% Pos 0%

Baird analyst David Rescott maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price target from $93 to $85.

Comments

No comments yet. Be the first!